Found 3824 chains in Genus chains table. Displaying 1101 - 1150. Applied filters: Proteins

Search results query: proteasome subunit alpha type-2

Total Genus Sequence Length pdb Title
59 353 5m32c Human 26s proteasome in complex with oprozomib
40 203 5m32N Human 26s proteasome in complex with oprozomib
44 230 5m32A Human 26s proteasome in complex with oprozomib
39 233 5m32D Human 26s proteasome in complex with oprozomib
43 221 5m32H Human 26s proteasome in complex with oprozomib
62 211 5lttK Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
70 242 5lttD Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
18 205 5m32j Human 26s proteasome in complex with oprozomib
4 26 5m32s Human 26s proteasome in complex with oprozomib
46 342 5m32d Human 26s proteasome in complex with oprozomib
51 301 5m32i Human 26s proteasome in complex with oprozomib
64 231 5m2bE Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
97 422 5m32l Human 26s proteasome in complex with oprozomib
59 226 5m2bH Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
63 241 5l6cG Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
57 196 5l62N Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
61 222 5l63L Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
69 244 5l63B Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
58 226 5l64H Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
67 211 5l60K Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
67 233 5l60M Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
64 231 5l65E Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib
61 195 5l5vJ 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
61 231 5l63E Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
63 241 5l62G Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
68 240 5l63C Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
66 250 5l62A Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
60 222 5l62L Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
69 244 5l5xB Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
68 233 5l62M Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
65 233 5l5dM Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
57 195 5l5wJ Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133)
65 250 5l61A Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
59 196 5l63N Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
59 226 5l68H Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
72 240 5l5xC Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
33 274 5m32q Human 26s proteasome in complex with oprozomib
70 243 5l61F Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
66 250 5l68A Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
66 242 5l64D Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
70 243 5l68F Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
58 204 5l68I Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
69 243 5l66F Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
64 231 5l66E Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
65 211 5l65K Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib
66 211 5l66K Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
59 196 5l5iN Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9
59 196 5l67N Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924
63 241 5l5yG Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
66 250 5l5uA Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17